Effects of Duodenal-Jejunal Bypass Liner (EndoBarrier®) on Gastric Emptying in Obese and Type 2 Diabetic Patients

Obesity Surgery

Volumn 25, Issue 9, 2015, Pages 1618-1625

  de Moura, Eduardo Guimarães Hourneaux ^a   Lopes, Guilherme Sauniti ^a   da Costa Martins, Bruno ^a   Orso, Ivan Roberto Bonotto ^a   Coutinho, Artur Martins Novaes ^a   de Oliveira, Suzana Lopes ^a   Sakai, Paulo ^a   dos Passos Galvão Neto, Manoel ^b   Santo, Marco Aurélio ^a   Sapienza, Marcelo Tatit ^a   Cecconello, Ivan ^a   Buchpiguel, Carlos Alberto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Gastro Obeso Center   (Brazil)

Author keywords

Diabetes mellitus; Duodenum surgery; Endoscopy; Gastric emptying; Obesity; Type 2 radionuclide imaging

Indexed keywords

GLIBENCLAMIDE; GLICLAZIDE; GLYCOSYLATED HEMOGLOBIN; METFORMIN;

ADULT; AGED; ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; DEVICE REMOVAL; DIABETIC PATIENT; DUODENAL JEJUNAL BYPASS LINER; DUODENUM; FEMALE; HUMAN; IMPLANTATION; JEJUNUM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH EMPTYING; SURGICAL EQUIPMENT; WEIGHT REDUCTION; BARIATRIC SURGERY; DEVICES; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; OBESITY, MORBID; PROSTHESES AND ORTHOSES; SCINTISCANNING;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DUODENUM; FEMALE; GASTRIC EMPTYING; HUMANS; JEJUNUM; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES; PROSTHESES AND IMPLANTS;

EID: 84938414692     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-015-1594-x     Document Type: Article

References (28)

1. Organization, World Health. World Health Statistics. A snapshot of global health. World Health Organization, Geneve, Switzerland, 2012. http://www.who.int/gho/publications/world_health_statistics/EN_WHS2012_Brochure.pdf.
2. Guh DP, Zangh W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analyses. BMC Public Health. 2009;9(88):1–20.
3. Allison DB, Zanolli R, Narayan KMV. The direct health care costs of obesity in the United States. Am J Public Health. 1999;89:1194–9.
4. Flum DR, Dellinger EP. Impact of gastric bypass operation on survival: a population-based analysis. J Am Coll Surg. 2004;199:543–51.
5. Moura EGH, Martins BDC, Lopes GS, et al. Six months results of the duodenal-jejunal bypass liner for the treatment of obesity and type 2 diabetes. J Gastroenterol Dig Syst. 2012;S2:003.
6. Moura,EGH, Martins BC, Lopes GS, et al. Metabolic improvements in obese type 2 diabetes subjects implanted for 1 year with an endoscopically deployed duodenal–jejunal bypass liner. Diabetes Technol Ther. 2012;14(2).
7. Escalona A, Pimentel F, Sharp A, et al. Weight loss and metabolic improvement in morbidly obese subjects implanted for 1 year with an endoscopic duodenal-jejunal bypass liner. Ann Surg. 2012;255(6):1080–5.
8. Cohen RV, Neto MG, Correa JL, et al. A pilot study of the duodenal-jejunal bypass liner in low body mass index type 2 diabetes. J Clin Endocrinol Metab. 2013;98(2):E279–82.
9. Rohde U, Hedbäck N, Gluud LL, et al. Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies. BMJ Open. 2013;3(9):e003417.
10. Muñoz R, Escalona A. Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients. Curr Cardiol Rep. 2014;16(3):454.
11. Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for a pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23(3):650–6.
12. Dockray GJ. Cholecystokinin. Curr Opin Endocrinol Diab Obes. 2012;19(1):8–12.
13. Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejuna bypass sleeve: totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14(4):275–8.
14. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103(3):753–63.
15. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Gastroenterology. 2000;95(6):1456–62.
16. Escalona A, Yáñez R, Pimentel F, et al. Initial human experience with restrictive duodenal jejuna bypass liner for treatment of morbid obesity. Surg Obes Relat Dis. 2010;6(2):126–31.
17. Said G, Goulon-Goeau C, Slama G, et al. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus. A clinical and pathological study. N Engl J Med. 1992;326(19):1257–63.
18. Waseem S, Moshiree B, Draganov PV. Gastroparesis: current diagnostic challenge and management considerations. World J Gastroenterol. 2009;15(1):25–37.
19. Guyton A, Hall J. Textbook of medical physiology. 11th ed. Philadelphia: WB Saunders; 2006. p. 771–807.
20. De Ponti F, Azpiroz F, Malagelada JR. Reflex gastric relaxation in response to distention of the duodenum. Am J Physiol. 1987;252(5 Pt 1):G595–601.
21. Azpiroz F, Malagelada JR. Perception and reflex relaxation of the stomach in response to gut distention. Gastroenterology. 1990;98(5 Pt 1):1193–8.
22. Lopasso FP, Sakai P, Gazi BM, et al. A pilot study to evaluate the safety, tolerance, and efficacy of a novel stationary antral balloon (SAB) for obesity. J Clin Gastroenterol. 2008;42(1):48–53.
23. Levine A, Ramos A, Escalona A, et al. Radiographic appearance of endoscopic duodenal-jejunal bypass liner for treatment of obesity and type 2 diabetes. Surg Obes Relat Dis. 2009;5(3):371–4.
24. Hellström PM, Näslund E. Interactions between gastric emptying and satiety, with special reference to glucagon like peptide-1. Physiol Behav. 2001;74(4–5):735–41.
25. Ueno H, Yamaguchi H, Mizuta M, et al. The role of PYY in feeding regulation. Regul Pept. 2008;145(1–3):12–6.
26. Hellstrom PM, Gryback P, Jacobsson H. The physiology of gastric emptying. Best Pract Res Clin Anaesthesiol. 2006;20(3):397–407.
27. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg. 2006;244(5):741–9.
28. de Jonge C, Rensen SS, Verdam FJ, et al. Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes. Obes Surg. 2013;23(9):1354–60.